TARS Tarsus Pharmaceuticals, Inc.: institutional ownership and insider trading
270 funds reported holding $3.41B of Tarsus Pharmaceuticals, Inc. in their latest 13F filings; in Q2 2026 funds net bought $130M, with 37 new positions and 34 funds selling out; over the last 12 months insiders bought $0 and sold $20.0M on the open market.
Famous investors holding TARS
- Izzy Englander (Millennium Management): $91.7M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $44.7M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $17.3M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $2.27M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $585K, 0.0% of the portfolio
Largest institutional holders of TARS
- BlackRock, Inc. (BLK) — $243M
- Deep Track Capital, LP — $231M
- RTW INVESTMENTS, LP — $211M
- VANGUARD GROUP INC — $196M
- Jupiter Topco LLC — $177M
- Paradigm Biocapital Advisors LP — $175M
- JANUS HENDERSON GROUP PLC (JHG) — $157M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $115M
- VANGUARD CAPITAL MANAGEMENT LLC — $113M
- JENNISON ASSOCIATES LLC — $105M
Recent TARS insider trades
- Sep 15, 2026: Link William J Phd sold 12,500 shares ($980K)
- Sep 4, 2026: Neervannan Seshadri sold 4,564 shares ($388K)
- Sep 4, 2026: Azamian Bobak R. sold 10,000 shares ($906K)
- Sep 4, 2026: Lin Elizabeth Yeu sold 13,953 shares ($1.22M)
5%+ owners
- Deep Track Capital, LP: 8.5% (Schedule 13G/A, filed May 15, 2026)
- JANUS HENDERSON GROUP Ltd.: 6.5% (Schedule 13G/A, filed Aug 13, 2026)
- JANUS HENDERSON GROUP PLC: 5.3% (Schedule 13G, filed May 15, 2026)